ARDELYX, INC. Debt Instrument, Fee Amount
ARDELYX, INC. (ARDX) had Debt Instrument, Fee Amount of $4.84 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFeeAmount · last filed 2026-08-06
- 2026-06-30: Debt Instrument, Fee Amount $4.84M.
- 2026-03-31: Debt Instrument, Fee Amount $4.55M.
- 2025-12-31: Debt Instrument, Fee Amount $3.96M.
- 2025-09-30: Debt Instrument, Fee Amount $3.36M.
| Period end | Debt Instrument, Fee Amount | Debt Instrument, Fee Amount as first filed |
|---|---|---|
| 2026-06-30 | $4.84M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $4.55M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $3.96M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $3.36M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $2.77M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $2.37M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $1.99M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $3.30M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $3.65M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $4.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $734.00K 10-K · filed 2025-02-20 | $1.74M 10-K · filed 2024-02-22 |
| 2023-09-30 | $355.00K 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $529.00K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $699.00K 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $1.04M 10-K · filed 2023-03-02 | |
| 2022-09-30 | $1.14M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.23M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.32M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $532.00K 10-K · filed 2022-02-28 | |
| 2021-09-30 | $692.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $853.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.01M 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |